Gastroduodenal ulceration in small animals is a complex and important comorbidity that occurs when the physiological homeostasis of the gastrointestinal tract is disrupted secondary to administration of medications or the presence of local or systemic diseases. The aim of this article is to provide a comprehensive review of the veterinary literature regarding the pathophysiology, epidemiology, and risk factors associated with gastroduodenal ulceration in small animals. Pertinent concepts from the human literature will be integrated into the discussion. This article serves as an introduction to the second part of this series, which will review current evidence regarding the use of H2-receptor
production. 7, 8 This is different than the situation in humans, in whom the majority of intrinsic factor is produced in the stomach.
The parietal cells are responsible for the production of HCl via a highly specialized ultrastructure. 
Regulation of Acid Secretion
Gastric acid secretion is tightly regulated by a combination of hormonal and paracrine factors as well as nervous stimuli.
Secretion is separated into three phases: the cephalic, the gastric, and the intestinal. The cephalic phase of secretion is controlled primarily by parasympathetic stimulation via the vagus nerve in response to external stimuli such as food, taste, or smell. 2,9 Efferent vagal nerve fibers release acetylcholine, which binds to muscarinic receptors on the parietal cells, ECL cells, and G cells. 9 In parietal cells, this leads to the generation of inositol trisphosphate (IP3) and opening of the IP3 receptor on the endoplasmic reticulum which increases the intracellular calcium concentration. 2 This increase in intracellular calcium is coupled to movement of the proton pump to the apical membrane of the parietal cell. The net result is the release of hydrogen ions into the lumen. Binding of acetylcholine to muscarinic receptors also stimulates the release of histamine from ECL cells and gastrin from G cells. 1 In the gastric phase, secretion is stimulated by the parasympathetic nervous system, which activates mechanoreceptors on mucosal cells in response to luminal distension (the so-called vagovagal reflex). 2 In addition to control of acid secretion, the parasympathetic system (vagal nerve) also stimulates the secretion of mucus, bicarbonate, and pepsinogen from mucous and peptic cells. 1, 2 Histamine is an important mediator of gastric acid secretion.
An important source of histamine is the ECL cells, which lie in close proximity to the parietal cells. 10 Histamine release by the ECL cells is stimulated not only by release of acetylcholine as noted above, but also by the binding of gastrin to cholecystokinin 2 receptors on the ECL cells. 1, 9, 11 Histamine released by the ECL cell Gastrin is a hormone synthesized by G cells. Four main forms of gastrin have been reported in humans, dogs, and cats. 12 They are commonly named according to the number of amino acids (G14, G17, G34, G71) or by component number (Gastrin component I, II, III, and IV). In cats, only component III (G17) and a very small proportion of component IV (G14) have been isolated in the gastric lumen. 12 In dogs, components I (G71), II (G34) and III (G17) are secreted in the gastric lumen. 12 Gastrin exerts a trophic 
Gastric Homeostasis and Pathophysiology of Gastric Ulceration
Despite the harsh environment, the integrity of the stomach is preserved by an intricate system of homeostatic mechanisms.
Gastric pH in dogs and cats, similar to humans, is acidic. 15, 16 In dogs, gastric pH is influenced by the presence of food, with fasting pH being significantly higher than in the fed state. 16, 17 In addition to acidic fluid, the stomach is exposed daily to numerous harmful substances, such as proteolytic enzymes, medications, microorganisms, and potential toxins in ingested foods. 9, 18, 19 Protection against these substances, as well as gastric acid, is essential in preventing cell injury leading to gastric erosion or ulceration.
Gastric injury occurs when noxious factors overwhelm the natural defenses, as seen when there is overproduction of gastric acid, and also when there is impairment of the gastric cytoprotective defense mechanisms. 9, 18 The cytoprotective mechanisms in the stomach can be divided The first line of defense and one of the most important cytoprotective mechanisms is the presence of a hydrophobic unstirred layer of bicarbonate-buffered mucus that is immediately adherent to the surface epithelial cells. 21 The mucus in this layer, which is secreted by the epithelial cells, traps bicarbonate, water, and trefoil factor peptides to form a gel-like structure that is closely associated with the surface epithelial cells and effectively protects them from injury. 18, 20, 22, 23 The surface epithelial cells themselves provide a second line of defense. They have hydrophobic membranes that are interconnected via tight junctions that provide a barrier resistant to the back diffusion of acid. 18, 24, 25 The epithelial cell surface is also continuously renewed by proliferation of progenitor cells in the gastric glands, allowing the complete restitution of the gastric surface in a few days. 18 This rapid turnover is supported by trophic factors, such as epidermal growth factor and insulin-like growth factor, and a high mucosal microcirculation that delivers oxygen and nutrients to the cells. (PGE2 and PDI2) . 18, 20, 21, 26, 27 In addition, prostaglandins decrease epithelium permeability, the release of pro-inflammatory cytokines, and favor ulcer healing by stimulating reepithelialization. 19 Over the past decades, both of the prostaglandin-producing enzymes, cyclo-oxygenase 1 (COX-1) and cyclo-oxygenase 2 (COX-2), have been extensively studied. Initially, their roles were thought to be very distinct, with COX-1 being a ''house-keeping''
constitutively expressed enzyme responsible for the basal production of PGs, and COX-2 being an inducible enzyme upregulated with inflammation with little role in the maintenance of mucosal integrity. 27 (64-80%), mainly normocytic and normochromic, were the most common findings. In one study, serum alkaline phosphatase and serum alanine transferase activity were increased in 65 and 38% of the cases, respectively, but this was not seen in other studies. 31 Hypoalbuminemia was frequently reported (60-87%). Ulceration and perforation have been reported in all areas of the dog's stomach and in the proximal duodenum, with the pyloric antrum being the most common site for NSAID-induced lesions. In one study, perforations secondary to ulcers were noticed more frequently at the parietal side of the stomach and the antimesenteric side of the duodenum. 34 In dogs with liver diseases, ulcers are more frequently present at the level of the duodenum. 31, 35, 39 In both dogs and cats, abdominal ultrasound, abdominal radiographs, and endoscopy are the most commonly reported imaging modalities used to diagnose gastroduodenal ulceration or perforation. [31] [32] [33] [34] 38 Endoscopy is considered the gold standard for the diagnosis of gastroduodenal ulceration. However, endoscopy detected gastroduodenal perforation in only 17-67% of the dogs depending on the study, was rarely performed in cats, and has been associated with gastrointestinal perforation in predisposed patients (Figure 2) . [30] [31] [32] 38, 40 An inability to visualize the gastric lesion has been attributed to excessive bleeding, presence of a mass, and/or excessive fluid or food retention. 32 In one retrospective study, abdominal ultrasound and radiographs accurately diagnosed gastrointestinal perforation in 73 and 65% of cases, respectively. 41 The most common ultrasonographic findings in both cats and dogs (Figure 4) . 31, 34, 38, 41 It is also important to note that not all gastroduodenal ulcers are perforated.
In non-perforated ulcers, some of the previously described features will be absent, and changes will be more subtle (e.g., gas dissecting the gastric mucosa on ultrasound) (Figure 3 ). This likely decreases the sensitivity of ultrasound and radiographs and reduces the ability to detect non-perforated gastroduodenal ulcerations or erosions.
Similar to dogs, cats with gastric ulcerations also exhibit nonspecific clinical signs such as decreased appetite (61-86%), vomiting (61-86%), or weight loss (38-100%). 30, 32, 38 As in dogs, hematemesis (0-22%) and melena (7-28%) are rarely reported in cats. The most common hematological changes are neutrophilia (62-86%), left shift (0-57%), and anemia (25-71%). On the biochemistry profile, hypoproteinemia, primarily due to hypoalbuminemia, was the most frequently reported abnormality (29-100%). 30, 32, 34 The most common causes of gastroduodenal ulceration in dogs and cats are summarized in Table 1 .
The use of NSAIDs has been linked to gastroduodenal ulceration in many species, including dogs, cats, and humans. 9, 28, 33, 38, [42] [43] [44] [45] [46] [47] [48] Gastric mucosal damage from NSAIDS can be from direct toxicity or from inhibition of prostaglandin synthesis. 
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the surface-active phospholipids within the mucous gel layer, thereby reducing their hydrophobic properties.
9,49
Suppression of prostaglandin synthesis, however, is the major toxic effect of NSAIDs on the gastric epithelium. Since COX-1 is constitutively expressed and COX-2 is an inducible enzyme, it was originally felt that inhibition of COX-1 was the main mechanism for the gastrointestinal side effects of NSAIDs. 28, 50 This led to the development of NSAIDs with more specific COX-2 inhibition. In humans, COX-2 inhibitors are associated with slightly less gastrointestinal side effects than non-specific NSAIDs, although severe gastrointestinal side effects still occur. 46 Studies looking at the safety of COX-2-selective NSAIDs in dogs have not shown a clear-cut advantage over nonselective COX inhibitors. Several studies describe gastric ulceration associated with COX-2-specific NSAIDs. 43, 44, 47, 51, 52 Reasons behind this difference in dogs compared to humans may be multifactorial, and include a potential lack of statistical power in the veterinary studies, inaccurate assessment of the COX-2 specificity of the NSAIDs, and individual variability. 28, 52, 53 Moreover, diverse studies show that COX-1 expression is not essential in preventing or healing gastroduodenal ulceration, but that induction of COX-2 is essential for ulcer healing and resolution. 28, 52, 54 The role of corticosteroids on gastroduodenal ulceration is controversial. Older meta-analyses in human medicine found little to no increased risk of gastric ulcer with administration of corticosteroids. [55] [56] [57] However, a more recent meta-analysis found that corticosteroids increased the risk of gastrointestinal bleeding by 40% in hospitalized patients. 58 In humans, the major risk of corticosteroid-induced gastric ulceration is the presence of other risk factors such as concurrent NSAID administration, gastrointestinal neoplasia or inflammation, older age, and smoking. 31, 32, 59, 60 In dogs, the combination of NSAIDs and corticosteroids also appears to promote gastric ulceration more than the administration of either NSAIDs or corticosteroids alone. 61, 62 The cause for this synergistic effect with supraphysiologic doses of corticosteroids is not completely understood.
Paradoxically, physiologic levels of corticosteroids are necessary to maintain intestinal epithelial integrity, as they are important in maintaining normal gastric blood flow and mucus production. 63 In rats, NSAID-induced lesions are significantly worse in adrenalectomized animals and dogs with hypoadrenocorticism are predisposed to developing gastrointestinal bleeding. 3, [63] [64] [65] In dogs and humans, gastroduodenal ulcerations occur in association with brain or spinal cord injury, especially injury secondary to intervertebral disc disease. [66] [67] [68] [69] In the veterinary studies, macroscopic and/or microscopic gastroduodenal erosions or ulcerations occur in 76% of dogs with spinal cord injury. 66, 67 Many of the dogs with gastric lesions also received corticosteroids In humans, stress-associated gastric mucosal ulceration occurs in up to 75-100% of patients hospitalized in the intensive care unit. 70, 71 More importantly, 50% of these patients who go on to develop gastrointestinal bleeding from these ulcers eventually die from this complication. 72 It is important to note that the ''stress'' described in these situations is pathologic stress secondary to severe systemic disease, which typically includes respiratory failure with mechanical ventilation, sepsis, coagulopathy, or thromboembolism. 72 The two strongest predictors of stress-associated mucosal ulceration in humans are coagulopathy and respiratory failure. 72 Length of hospitalization, male gender, sepsis, spinal cord injury, and acute renal failure are also risk factors. 73 The pathophysiology of stress-related mucosal ulceration is incompletely understood, but a proposed mechanism is that disruption of the gastric microcirculation promotes gastric epithelial hypoperfusion, ischemia, and acidosis. 70 Decreased epithelial cell turnover, gastrointestinal hypomotility, gastric edema, cytokine release, and the Hypoadrenocorticism presence of increased gastric acidity, which impairs platelet aggregation and promotes clot lysis, may also play a role. 70, 74 Lastly, reperfusion injury that occurs once the microcirculation is restored can further damage the gastric mucosa by production of oxygen radicals.
No studies of stress-related mucosal ulceration in critically ill dogs or cats have been done, so whether this gastric pathology occurs in small animals is unknown. Currently, there is no evidence in the literature to support that simple stress, such as hospitalization, is a risk factor for gastrointestinal ulceration. However, a recent study of people who survived the 2011 great earthquake and tsunami in Japan showed a significant increase in gastroduodenal ulceration. 75, 76 In some case series on gastroduodenal ulceration or perforation in dogs and cats, liver disease was a common risk factor. 31, 32 Unfortunately, these studies provided little detail on the type of liver disease. Therefore, the exact nature of the association between liver disease and gastroduodenal ulceration in small animals is unclear. Recently, a high incidence of gastrointestinal ulceration and bleeding (up to 21%) was described in dogs with congenital intra-hepatic shunts. 36 In addition, duodenal perforation has been described as a co-morbidity in dogs with noncirrhotic portal hypertension. 35 Recent results also suggest that gastrointestinal bleeding is a common complication in dogs with acute liver failure. 81 Association between gastrointestinal ulceration and chronic liver disease exists in humans, particularly those with portal hypertension. 39 The pathophysiology of gastric erosion or ulceration in dogs with liver disease is unknown. A recent study
showed that serum gastrin concentration in dogs with hepatocellular diseases and porto-systemic shunts was normal, so hyperacidity due to poor gastrin clearance is likely not an important factor. 82 Other possibilities for gastric damage in hepatic disease include impaired gastric mucus and bicarbonate secretion, microvascular abnormalities, bile acid-induced epithelial cell apoptosis, impaired healing ability of the gastric mucosa, and portal hypertension. 83 The role of portal hypertension in humans, however, has recently been questioned. 39, 84 In human medicine, severe acute pancreatitis promotes gastroduodenal ulceration, with a prevalence of 52.6% in the studied population. 85 In dogs with acute pancreatitis, up to 10% had evidence of gastrointestinal bleeding even if the exact location or cause of the bleeding was not assessed. 86 Presence of gastrointestinal bleeding was also associated with a worse outcome. 86 One risk factor for gastroduodenal ulceration shared by both dogs and cats is gastrointestinal inflammation. [30] [31] [32] 38, 87 In human patients, Helicobacter pylori is a significant risk factor for gastritis and gastric ulceration. 88 It affects more than 50% of humans in the world, and 10% of them will develop peptic ulcers. 88 and enteritis. 93 In this study, dogs with inflammatory bowel disease had a significantly higher gastrin level than control dogs, and this could explain the increased incidence of ulceration in this population. This finding is similar to what has been previously described in basenjis with severe familial enteropathy. 94 This increase in gastrin secretion could be secondary to biliary reflux from the duodenum into the gastric antrum, which distends and alkalinizes gastric contents and subsequently stimulates the secretion of gastrin. Pathophysiology of gastroduodenal ulceration in small animals with gastrointestinal inflammation is very likely multifactorial and potentially involves decreased cellular turnover, increased inflammatory cytokines, and impaired microcirculation.
Strenuous exercise such as long sled races predisposes dogs to gastroduodenal ulceration. 95, 96 This predisposition also occurs in horses and humans secondary to extreme exercise. 97, 98 In sled dogs, the severity of the gastric lesions is associated with the intensity but not the duration of exercise. Transient ischemia of the gastroduodenal mucosa is thought to represent the major mechanism of ulceration with strenuous exercise. Further causative factors could include sustained catecholamine secretion, increased tumor necrosis factor-alpha level, hypergastrinemia, and gastric hypomotility. 95, 98 Neoplasia can cause gastroduodenal ulceration in dogs and cats. [30] [31] [32] 38, 99 In cats, infiltrative neoplasia of the gastrointestinal tract, such as mast cell tumors or lymphoma, is one of the most common causes of gastroduodenal ulceration. 30, 32, 38 In dogs, infiltrative neoplasia has been less commonly reported to cause gastroduodenal ulceration. 31, 32 Paraneoplastic syndromes associated with mast cell tumors and gastrinomas cause erosions or ulcers due to the effects of excess production of histamine and gastrin, respectively, on the gastric mucosa. Serum histamine concentration is significantly increased in dogs with mast cell tumors. 99 Gastrinomas are non-b-islet cell tumors of the pancreas or, more rarely, of extrapancreatic tissue such as the duodenum. 100 Gastrinomas promote gastric ulceration by autonomous gastrin hypersecretion and severe gastric hyperacidity. 101 
Conclusion
Gastroduodenal ulceration is a complex and potentially lifethreatening condition in small animals. The gastric epithelium must be constantly protected from a harsh luminal environment consisting of acid and digestive enzymes. When the intricate gastric cytoprotective mechanisms fail, epithelial damage occurs. The clinical presentation and laboratory tests in dogs and cats with gastric erosions or ulcers are often non-specific, and imaging may only be abnormal in very severe disease. Thus, it is important for the clinician to have a high index of suspicion that gastrointestinal ulceration may exist and be able to recognize the common comorbidities associated with gastric erosion/ulceration in dogs and cats, such as the administration of anti-inflammatory treatments, neoplasia, gastrointestinal inflammation, spinal injuries, liver disease, and hemodynamic disturbances in order to make a timely diagnosis. The second part of this series will discuss drug therapy to prevent and/or treat gastric ulcer disease.
